Serum amyloid A protein has been undervalued as a biomarker of COVID-19

Diabetes Metab Res Rev. 2021 Jan;37(1):e3376. doi: 10.1002/dmrr.3376. Epub 2020 Jul 18.

Authors

Carlos-Alberto Gonçalves¹, Patrícia Sesterheim²

Affiliations

¹ Department of Biochemistry, University Federal of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
² Experimental Cardiology Center, Institute of Cardiology of Rio Grande do Sul, Porto Alegre, Brazil.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
COVID-19*
Diabetes Mellitus*
Humans
Prognosis
Risk Factors
SARS-CoV-2
Serum Amyloid A Protein / analysis

Substances

Biomarkers
Serum Amyloid A Protein